Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial
Authors
Lucinda Jane Billingham (ORCID: https://orcid.org/0000-0001-8581-4262)
Wojciech Michal Mlynarski (ORCID: https://orcid.org/0000-0003-2714-5851)
Heather Rose (ORCID: https://orcid.org/0000-0002-0346-1334)
Patrick Yu‐Wai‐Man (ORCID: https://orcid.org/0000-0001-7847-9320)
Kun Hu (ORCID: https://orcid.org/0000-0002-0981-1745)
Centre Hospitalier Régional Universitaire de Montpellier
Moorfields Eye Hospital NHS Foundation Trust
Moorfields Eye Charity
Medical Research Council
Birmingham Biomedical Research Centre
NIHR Cambridge Biomedical Research Centre
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial
Lucinda Jane Billingham, Wojciech Michal Mlynarski, Heather Rose, Patrick Yu‐Wai‐Man et al.
Citations
3 citations
Journal
BMJ Open
Topics
Genetics and Neurodevelopmental Disorders
Field-Weighted Citation Impact (FWCI)
5.45
article
Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial
Lucinda Jane Billingham, Wojciech Michal Mlynarski, Heather Rose, Patrick Yu‐Wai‐Man, Kun Hu, Ruth Evans, Zsuzsanna Nagy, Martin Wilson, Kristian Brock, Isabelle Meunier, Timothy Barrett, Sabrina Cronier, Gema Esteban-Bueno, Agathe Roubertie, Una Martin, Avleen Malhi, Pooja Takhar, Sulev Kõks, Christophe Orssaud, Malgorzata Zatyka, Victoria Homer, Susan P. Mollan, Rebecca Malpass, Darren Barton, Renuka Dias, A. B. Lamb, Thomas R. Lynch, Dewi Astuti, Andrew C. Peet, Karen Morrison, Archana Kulkarni, Rajat Gupta, Benjamin Wright
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
Queen's University Belfast (GB), University Hospitals Birmingham NHS Foundation Trust (GB), Moorfields Eye Hospital NHS Foundation Trust (GB), Nottingham University Hospitals NHS Trust (GB), Inserm (FR), Murdoch University (AU), Université de Montpellier (FR), University of Cambridge (GB), Queen Elizabeth Hospital Birmingham (GB), Biobanco del Sistema Sanitario Público de Andalucía (ES), Centre Hospitalier Universitaire de Montpellier (FR), Birmingham Women's Hospital (GB), Birmingham Children's Hospital (GB), Hôpital Gui de Chauliac (FR), Medical University of Lodz (PL), Institute for Neurosciences of Montpellier (FR), Cancer Research UK Clinical Trials Unit (GB), ERN GUARD-Heart (NL), Moorfields Eye Hospital (GB), Birmingham Women’s and Children’s NHS Foundation Trust (GB), Addenbrooke's Hospital (GB), University College London (GB), MRC Mitochondrial Biology Unit (GB), University of Birmingham (GB)
Funders
Hope Foundation, Eye Hope Foundation, Cancer Research UK, National Institute for Health and Care Research, Sight Research UK, Isaac Newton Trust, Centre Hospitalier Régional Universitaire de Montpellier, Moorfields Eye Hospital NHS Foundation Trust, Moorfields Eye Charity, Medical Research Council, Birmingham Biomedical Research Centre, NIHR Cambridge Biomedical Research Centre